{
    "Trade/Device Name(s)": [
        "Sofia Influenza A+B FIA"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K131606",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "July 5, 2013",
    "Summary Letter Received Date": "June 05, 2013",
    "Submission Date": "May 30, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasopharyngeal aspirate/wash"
    ],
    "Specimen Container(s)": [
        "Reagent Tube",
        "Cassette sample well"
    ],
    "Instrument(s)/Platform(s)": [
        "Sofia Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence",
        "Lateral-flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Fluorescent signal detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Analyzer",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for Sofia Influenza A+B FIA immunofluorescence assay using Sofia Analyzer to detect influenza A and B antigens in respiratory specimens.",
    "Indications for Use Summary": "Aids in rapid differential diagnosis of acute influenza A and B viral infections in nasal and nasopharyngeal specimens from symptomatic patients; intended for professional and laboratory use.",
    "fda_folder": "Microbiology"
}